CA
NZ
UK
AU
IND
US
…
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | 1928.00M | 2800.00M | 2404.00M | 1954.00M | 2193.00M |
| Minority interest | -16.00M | -17.00M | -18.00M | 13.00M | 13.00M |
| Net income | 1509.00M | 2038.00M | 1727.00M | 1411.00M | 1567.00M |
| Selling general administrative | 3607.00M | 3408.00M | 2817.00M | 2279.00M | 2214.00M |
| Gross profit | 7709.00M | 8137.00M | 6952.00M | 5580.00M | 5796.00M |
| Reconciled depreciation | 1557.00M | 1343.00M | 1039.00M | 815.00M | 620.00M |
| Ebit | 2224.00M | 2918.00M | 2476.00M | 1996.00M | 2316.00M |
| Ebitda | 3781.00M | 4261.00M | 3515.00M | 2811.00M | 2936.00M |
| Depreciation and amortization | 1557.00M | 1343.00M | 1039.00M | 815.00M | 620.00M |
| Operating income | 2224.00M | 2918.00M | 2476.00M | 1996.00M | 2316.00M |
| Other operating expenses | 19547.00M | 18790.00M | 15440.00M | 12516.00M | 12222.00M |
| Interest expense | 296.00M | 118.00M | 83.00M | 76.00M | 123.00M |
| Tax provision | 403.00M | 746.00M | 658.00M | 532.00M | 607.00M |
| Interest income | 85.00M | 48.00M | 33.00M | 53.00M | 38.00M |
| Net interest income | -207.00M | -127.00M | -170.00M | -28.00M | -107.00M |
| Income tax expense | 403.00M | 746.00M | 658.00M | 532.00M | 607.00M |
| Total revenue | 21680.00M | 21714.00M | 17997.00M | 14460.00M | 14518.00M |
| Total operating expenses | 5576.00M | 5213.00M | 4395.00M | 3636.00M | 3500.00M |
| Cost of revenue | 13971.00M | 13577.00M | 11045.00M | 8880.00M | 8722.00M |
| Total other income expense net | -296.00M | -118.00M | -72.00M | -42.00M | -123.00M |
| Net income from continuing ops | 1525.00M | 2054.00M | 1746.00M | 1422.00M | 1586.00M |
| Net income applicable to common shares | - | 2038.00M | 1727.00M | 1411.00M | 1567.00M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Total assets | 46684.00M | 49056.00M | 42162.00M | 25094.00M | 21429.00M |
| Intangible assets | 7726.00M | 8712.00M | 8211.00M | 1912.00M | 1576.00M |
| Other current assets | 25.00M | 28.00M | 25.00M | 27.00M | 12.00M |
| Total liab | 28551.00M | 29204.00M | 25823.00M | 12583.00M | 11647.00M |
| Total stockholder equity | 18081.00M | 19836.00M | 16321.00M | 12498.00M | 9769.00M |
| Other current liab | 168.00M | 178.00M | 213.00M | 136.00M | 148.00M |
| Common stock | 1128.00M | 1128.00M | 1128.00M | 1075.00M | 1000.00M |
| Capital stock | 1128.00M | 1128.00M | 1128.00M | 1075.00M | 1000.00M |
| Retained earnings | 1381.00M | 894.00M | -300.00M | -1276.00M | -1859.00M |
| Other liab | - | 3369.00M | 3594.00M | 1998.00M | 1951.00M |
| Good will | 18118.00M | 19061.00M | 17512.00M | 9038.00M | 8590.00M |
| Other assets | - | 4070.00M | 2141.00M | -1.00M | 1429.00M |
| Cash | 1642.00M | 1436.00M | 1322.00M | 656.00M | 920.00M |
| Total current liabilities | 13440.00M | 12024.00M | 10065.00M | 7289.00M | 5605.00M |
| Current deferred revenue | 10872.00M | 9282.00M | 7682.00M | 5630.00M | 3974.00M |
| Net debt | -1009.00M | -704.00M | -569.00M | -175.00M | -779.00M |
| Short term debt | 197.00M | 249.00M | 249.00M | 167.00M | 80.00M |
| Short long term debt | 31.00M | 67.00M | 73.00M | 60.00M | 70.00M |
| Short long term debt total | 633.00M | 732.00M | 753.00M | 481.00M | 141.00M |
| Other stockholder equity | 15572.00M | 17814.00M | 15493.00M | 12699.00M | 10628.00M |
| Property plant equipment | - | 3632.00M | 3295.00M | 2510.00M | 1944.00M |
| Total current assets | 14136.00M | 13379.00M | 10824.00M | 10268.00M | 7779.00M |
| Long term investments | - | - | - | - | 132.00M |
| Net tangible assets | - | -7937.00M | -9493.00M | 1548.00M | -397.00M |
| Short term investments | 124.00M | 162.00M | 79.00M | 31.00M | 28.00M |
| Net receivables | 8084.00M | 7781.00M | 6244.00M | 7280.00M | 4773.00M |
| Long term debt | 10.00M | 15.00M | 19.00M | 49.00M | 39.00M |
| Inventory | 4261.00M | 3972.00M | 3154.00M | 2274.00M | 2046.00M |
| Accounts payable | 2203.00M | 2315.00M | 1921.00M | 1356.00M | 1403.00M |
| Non currrent assets other | 1924.00M | 2925.00M | 1244.00M | 580.00M | 600.00M |
| Non current assets total | 32548.00M | 35677.00M | 31338.00M | 14827.00M | 13650.00M |
| Capital lease obligations | 592.00M | 650.00M | 590.00M | 372.00M | 32.00M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Investments | -1069.00M | 15.00M | 15.00M | -1.00M | -1.00M |
| Change to liabilities | - | 791.00M | 643.00M | 128.00M | 268.00M |
| Total cashflows from investing activities | - | -868.00M | -14140.00M | -1912.00M | -647.00M |
| Net borrowings | - | -169.00M | -155.00M | -101.00M | 52.00M |
| Total cash from financing activities | -690.00M | -1644.00M | 11839.00M | -249.00M | -603.00M |
| Change to operating activities | - | -663.00M | 453.00M | -39.00M | -140.00M |
| Net income | 1525.00M | 2054.00M | 1746.00M | 1423.00M | 1586.00M |
| Change in cash | 206.00M | 114.00M | 666.00M | -264.00M | 401.00M |
| Begin period cash flow | 1436.00M | 1322.00M | 656.00M | 920.00M | 519.00M |
| End period cash flow | 1642.00M | 1436.00M | 1322.00M | 656.00M | 920.00M |
| Total cash from operating activities | 2119.00M | 2504.00M | 2933.00M | 1928.00M | 1617.00M |
| Issuance of capital stock | - | 1.00M | 2311.00M | 2709.00M | - |
| Depreciation | 1557.00M | 1343.00M | 1039.00M | 815.00M | 620.00M |
| Other cashflows from investing activities | - | - | 1.00M | 1.00M | 1.00M |
| Dividends paid | -1066.00M | -955.00M | -856.00M | -798.00M | 699.00M |
| Change to inventory | -453.00M | -481.00M | -22.00M | -332.00M | -124.00M |
| Change to account receivables | - | -478.00M | -720.00M | 55.00M | -485.00M |
| Sale purchase of stock | -421.00M | -309.00M | -255.00M | -67.00M | -51.00M |
| Other cashflows from financing activities | 1354.00M | -232.00M | 10777.00M | -1853.00M | 147.00M |
| Change to netincome | - | -46.00M | -187.00M | -110.00M | -89.00M |
| Capital expenditures | 838.00M | 852.00M | 674.00M | 557.00M | 579.00M |
| Change in working capital | -602.00M | -831.00M | 354.00M | -188.00M | -481.00M |
| Other non cash items | -361.00M | -62.00M | -206.00M | -122.00M | -108.00M |
| Free cash flow | 1281.00M | 1652.00M | 2259.00M | 1371.00M | 1038.00M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SEMHF Siemens Healthineers AG |
-0.11 0.22% |
47.69 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
| ABT Abbott Laboratories |
1.63 1.56% |
106.20 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.57 0.59% |
96.54 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-19.89 6.38% |
291.86 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SMMNY Siemens Healthineers AG ADR |
-0.12 0.50% |
23.83 | 39.49 | 21.10 | 3.01 | 3.25 | 2.95 | 16.92 |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Henkestrasse 127, Erlangen, Germany, 91052
49 9131 84 3385
71000
| Name | Title | Year Born |
|---|---|---|
| Dr. Bernhard Montag | Pres, CEO & Chairman of Management Board | 1969 |
| Dr. Jochen Schmitz | CFO & Member of Management Board | 1966 |
| Ms. Darleen Caron | Chief HR Officer, Labor Director & Member of Management Board | 1964 |
| Ms. Elisabeth Staudinger | Member of Management Board | 1970 |
| Mr. Marc Koebernick | Head of Investor Relations | NA |
| Dr. Michel Therin D.V.M., Ph.D. | Pres of Advanced Therapies | 1961 |
| Christian Klaussner | Exec. VP of Fin. | NA |
| Andre Hartung | Head of Imaging | NA |
| Mr. Christopher A. Toth | Head of Varian | 1979 |
| Carsten Bertram | Head of Advanced Therapies | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...